- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00294827
Liver Transplantation and Metastatic Colo-rectal Cancer.
November 6, 2023 updated by: Magnus Smedman, MD, Oslo University Hospital
Survival of colo-rectal cancer patients after liver transplantation.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Survival, time to progression, other malignancy, side-effects, quality of life.
Study Type
Interventional
Enrollment (Estimated)
25
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Oslo, Norway, 0020
- Rikshospitalet-Radiumhospitalet HF
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:Colo-rectal cancer -
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Liver transplantation
|
Liver transplantation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Survival
Time Frame: 6 years
|
6 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Time to progression side-effects
Time Frame: 6 years
|
6 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Svein Dueland, MD, PhD, Rikshospitalet-Radiumhospitalet RRHF
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2006
Primary Completion (Estimated)
March 1, 2024
Study Completion (Estimated)
March 1, 2024
Study Registration Dates
First Submitted
February 21, 2006
First Submitted That Met QC Criteria
February 21, 2006
First Posted (Estimated)
February 22, 2006
Study Record Updates
Last Update Posted (Actual)
November 7, 2023
Last Update Submitted That Met QC Criteria
November 6, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- S-05409 (SECA I)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colo-rectal Cancer
-
Istituto Scientifico Romagnolo per lo Studio e...Istituto Oncologico Romagnolo (IOR)Recruiting
-
Chinese University of Hong KongUnknown
-
Fundación para el Fomento de la Investigación Sanitaria...UnknownNutrition Disorders | Colo-rectal Cancer
-
University of Roma La SapienzaCompletedColo-rectal Anastomosis Dehiscence
-
Region Örebro CountyActive, not recruitingColo-rectal Cancer | Gastrointestinal DiseaseSweden
-
Mathieu PiocheRecruiting
-
Assiut UniversityUnknownRecurrence | Colo-rectal Cancer
-
University of FloridaNational Cancer Institute (NCI)Completed
-
Assiut UniversityNot yet recruiting
-
QIAGEN Gaithersburg, IncAmgenRecruiting
Clinical Trials on Liver transplantation and colo-rectal cancer
-
Binh Dan HospitalCompleted
-
Oral and Maxillofacial Surgery Clinic, PolandRecruitingImpacted Third Molar Tooth | Impacted MolarPoland
-
University of ZurichUnknownDeath | ComplicationSwitzerland
-
Fudan UniversityCompletedRectal Neoplasm With Metastasis to the Liver
-
Austral University, ArgentinaCompleted
-
Ruijin HospitalRecruitingCarcinoma, Hepatocellular | Hepatitis C, Chronic | Hepatitis B, Chronic | Cirrhosis, Liver | Non-Alcoholic Fatty Liver DiseaseChina
-
Rutgers, The State University of New JerseyRecruitingIntrahepatic Cholangiocarcinoma | Cholangiocarcinoma, IntrahepaticUnited States
-
Oslo University HospitalRecruiting
-
University Health Network, TorontoCompleted
-
University of FloridaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedLiver Cancer | Hepatobiliary Tract Adenomas and CarcinomasUnited States